Trial Profile
A phase 0 study of EC0652 in patients with prostate cancer
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 07 Apr 2016
Price :
$35
*
At a glance
- Drugs EC 0652 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 07 Apr 2016 New trial record